Report Detail
Global Narcolepsy Drug Market Growth 2019-2024
- RnM2982969 |
- 19 February, 2019 |
- Global |
- 139 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse.
The global average price of narcolepsy drug is in the decreasing trend, from 43.3 K USD/Kg in 2012 to 35.7 K USD/Kg in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of narcolepsy drug includes antioxidants type, stimulants type and other types, and the proportion of antioxidants type in 2016 is about 78% in the world.
Narcolepsy drug is widely used for daytime extreme sleepiness, cataplexia and other field. The most proportion of narcolepsy drug is used for cataplexia, and the consumption proportion in 2016 is about 57%.
According to this study, over the next five years the Narcolepsy Drug market will register a 10.4% CAGR in terms of revenue, the global market size will reach US$ 3310 million by 2024, from US$ 1830 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Narcolepsy Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Narcolepsy Drug market by product type, application, key manufacturers and key regions and countries.
This study considers the Narcolepsy Drug value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Antioxidants Type
Stimulants Type
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Daytime Extreme Sleepiness
Cataplexia
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Jazz Pharmaceuticals
Teva Pharmaceutical
Novartis
Mylan
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Narcolepsy Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Narcolepsy Drug market by identifying its various subsegments.
Focuses on the key global Narcolepsy Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Narcolepsy Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Narcolepsy Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Narcolepsy Drug Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Narcolepsy Drug Consumption 2014-2024
- 2.1.2 Narcolepsy Drug Consumption CAGR by Region
- 2.2 Narcolepsy Drug Segment by Type
- 2.2.1 Antioxidants Type
- 2.2.2 Stimulants Type
- 2.2.3 Other
- 2.3 Narcolepsy Drug Consumption by Type
- 2.3.1 Global Narcolepsy Drug Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Narcolepsy Drug Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Narcolepsy Drug Sale Price by Type (2014-2019)
- 2.4 Narcolepsy Drug Segment by Application
- 2.4.1 Daytime Extreme Sleepiness
- 2.4.2 Cataplexia
- 2.4.3 Others
- 2.5 Narcolepsy Drug Consumption by Application
- 2.5.1 Global Narcolepsy Drug Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Narcolepsy Drug Value and Market Share by Application (2014-2019)
- 2.5.3 Global Narcolepsy Drug Sale Price by Application (2014-2019)
3 Global Narcolepsy Drug by Players
- 3.1 Global Narcolepsy Drug Sales Market Share by Players
- 3.1.1 Global Narcolepsy Drug Sales by Players (2017-2019)
- 3.1.2 Global Narcolepsy Drug Sales Market Share by Players (2017-2019)
- 3.2 Global Narcolepsy Drug Revenue Market Share by Players
- 3.2.1 Global Narcolepsy Drug Revenue by Players (2017-2019)
- 3.2.2 Global Narcolepsy Drug Revenue Market Share by Players (2017-2019)
- 3.3 Global Narcolepsy Drug Sale Price by Players
- 3.4 Global Narcolepsy Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Narcolepsy Drug Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Narcolepsy Drug Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Narcolepsy Drug by Regions
- 4.1 Narcolepsy Drug by Regions
- 4.1.1 Global Narcolepsy Drug Consumption by Regions
- 4.1.2 Global Narcolepsy Drug Value by Regions
- 4.2 Americas Narcolepsy Drug Consumption Growth
- 4.3 APAC Narcolepsy Drug Consumption Growth
- 4.4 Europe Narcolepsy Drug Consumption Growth
- 4.5 Middle East & Africa Narcolepsy Drug Consumption Growth
5 Americas
- 5.1 Americas Narcolepsy Drug Consumption by Countries
- 5.1.1 Americas Narcolepsy Drug Consumption by Countries (2014-2019)
- 5.1.2 Americas Narcolepsy Drug Value by Countries (2014-2019)
- 5.2 Americas Narcolepsy Drug Consumption by Type
- 5.3 Americas Narcolepsy Drug Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Narcolepsy Drug Consumption by Countries
- 6.1.1 APAC Narcolepsy Drug Consumption by Countries (2014-2019)
- 6.1.2 APAC Narcolepsy Drug Value by Countries (2014-2019)
- 6.2 APAC Narcolepsy Drug Consumption by Type
- 6.3 APAC Narcolepsy Drug Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Narcolepsy Drug by Countries
- 7.1.1 Europe Narcolepsy Drug Consumption by Countries (2014-2019)
- 7.1.2 Europe Narcolepsy Drug Value by Countries (2014-2019)
- 7.2 Europe Narcolepsy Drug Consumption by Type
- 7.3 Europe Narcolepsy Drug Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Narcolepsy Drug by Countries
- 8.1.1 Middle East & Africa Narcolepsy Drug Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Narcolepsy Drug Value by Countries (2014-2019)
- 8.2 Middle East & Africa Narcolepsy Drug Consumption by Type
- 8.3 Middle East & Africa Narcolepsy Drug Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Narcolepsy Drug Distributors
- 10.3 Narcolepsy Drug Customer
11 Global Narcolepsy Drug Market Forecast
- 11.1 Global Narcolepsy Drug Consumption Forecast (2019-2024)
- 11.2 Global Narcolepsy Drug Forecast by Regions
- 11.2.1 Global Narcolepsy Drug Forecast by Regions (2019-2024)
- 11.2.2 Global Narcolepsy Drug Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Narcolepsy Drug Forecast by Type
- 11.8 Global Narcolepsy Drug Forecast by Application
12 Key Players Analysis
- 12.1 Jazz Pharmaceuticals
- 12.1.1 Company Details
- 12.1.2 Narcolepsy Drug Product Offered
- 12.1.3 Jazz Pharmaceuticals Narcolepsy Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Jazz Pharmaceuticals News
- 12.2 Teva Pharmaceutical
- 12.2.1 Company Details
- 12.2.2 Narcolepsy Drug Product Offered
- 12.2.3 Teva Pharmaceutical Narcolepsy Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Teva Pharmaceutical News
- 12.3 Novartis
- 12.3.1 Company Details
- 12.3.2 Narcolepsy Drug Product Offered
- 12.3.3 Novartis Narcolepsy Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Novartis News
- 12.4 Mylan
- 12.4.1 Company Details
- 12.4.2 Narcolepsy Drug Product Offered
- 12.4.3 Mylan Narcolepsy Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Mylan News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Narcolepsy Drug . Industry analysis & Market Report on Narcolepsy Drug is a syndicated market report, published as Global Narcolepsy Drug Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Narcolepsy Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
